glp-1 ketosis is having a *moment* right now. Medications containing compounds that mimic the action of naturally produced GLP-1, commonly known as Ozempic and Wegovy, have become fashionable for combating weight gain. ✨While Ketone Body Induction: Insights into

Liraglutide (an older GLP-1 medication) significantly increased the incidence of adverse events compared to both semaglutide and tirzepatide

Now, the question is what food and beverage companies can and should do to overcome this challenge beyond cleaning labels and making products healthier (which should be a goal independently of our topic)

Training at least 3 times per week is ideal

But not without adverse events

Statements Author contributions SP researched and interpreted all the data from available scientific literature on the PUBMED database, organized, wrote and revised the whole manuscript

Ashley Koff, RD 00:19:07 So you can I do want to be very clear